Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
09/2005
09/15/2005WO2005051300A3 Bicyclic inhibitors of mek and methods of use thereof
09/15/2005WO2005044130A9 Pdk-1/akt signaling inhibitors
09/15/2005WO2005018547A3 Mitotic kinesin inhibitors
09/15/2005WO2004096792A3 Novel indole derivatives, method of preparing same in the form of medicaments, pharmaceutical compositions and, in particular, kdr inhibitors
09/15/2005US20050203296 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
09/15/2005US20050203161 Diphenylmethyl compounds useful as muscarinic receptor antagonists
09/15/2005US20050203160 Pyrazolylakoxy-substituted indoleacetic acid derivatives, e.g., {6-[2-methyl-5-(4-trifluoromethyl-phenyl)-2H-pyrazol-3-ylmethoxy]-indol-1-yl}-acetic acid; used for treatment and/or prevention of diseases modulated by PPAR delta and/or PPAR alpha agonists.
09/15/2005US20050203159 Calcium channel modulators 2-(alkyl or (hetero)arylalkylthio)-imidazoles and S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders
09/15/2005US20050203155 Imidazole compounds and human cellular proteins casein kinase I alpha, delta and epsilon as targets for medical intervention against Hepatitis C Virus infections
09/15/2005US20050203147 Biaryl heterocyclic compounds and methods of making and using the same
09/15/2005US20050203127 2-(Phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses
09/15/2005US20050203114 Pyrimidine-indole derivatives; cancer, autoimmunological, metabolic, inflammatory, infection (bacterial, viral, yeast, fungal, etc.), diseases of the central nervous system, degenerative neural disease, allergy/asthma, dermatology, angiogenesis, neovascularization, vasculogenesis, and cardiovascular
09/15/2005US20050203110 KINESIN SPINDLE PROTEIN INHIBITOR; ANTIPROLIFERATIVE AGENTS; ANTICANCER AGENTS; 4-(2,5-DIFLUOROPHENYL)-n-3 -FLUOROPYRROLIDIN-3-YL-2-HYDROXYMETHYL-2-PHENYL-2,5-DIHYDRO-1n-PYRROL-1-CARBOXAMIDE
09/15/2005US20050203104 Cycloalkyl - containing 5-acylindolinones, the preparation thereof and their use as medicaments
09/15/2005US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
09/15/2005US20050203078 Inhibitors of factor Xa or related serine proteases; thrombosis; benzamide derivatives with benzimidazole, indole or imidazo(1,2-a)pyridine rings; e.g. 4-(azepan-2-on-1-yl)-N-[(1R)-1-(5-chloro-1H-benzimidazol-2-yl)-2-methoxy-ethyl]-3-methyl-benzamide
09/15/2005DE102004010207A1 New 4-benzimidazolyl-3(2H)-pyridazinone derivatives are kinase inhibitors, especially useful for treatment of cancer
09/15/2005CA2558600A1 A substituted-trialkyl amine compound with anti-viral activity based on antagonism against a chemokine receptor cxcr4
09/15/2005CA2558278A1 Diaryl-substituted five-membered heterocycle derivative
09/15/2005CA2558211A1 Bicyclic and bridged nitrogen heterocycles
09/15/2005CA2557322A1 Inhibitors of hepatitis c virus ns3 protease
09/15/2005CA2555161A1 Novel 4-benzimidazol-2-yl-pyridazin-3-one derivatives
09/14/2005EP1572670A1 5-substituted-pyrazine or -pyridine glucokinase activators
09/14/2005EP1572669A2 2,5-diketopiperazines for the treatment of obesity
09/14/2005EP1572667A1 Cathepsin cysteine protease inhibitors and their use
09/14/2005EP1572664A1 Pyrazole compounds
09/14/2005EP1572662A1 Pyrazole and imidazole compounds and uses thereof
09/14/2005EP1572642A1 3-pyrrolyl urea derivatives and their use as antiviral agents
09/14/2005EP1572215A1 Benzo[d]azepine derivatives for the treatment of neurological disorders
09/14/2005EP1572209A1 Novel quinoxalinone derivatives as bradykinin b1 antagonists
09/14/2005EP1572200A1 Aminoindazole derivatives and use thereof as kinase inhibitors
09/14/2005EP1572199A2 Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity
09/14/2005EP1572129A2 Amidine derivatives for treating amyloidosis
09/14/2005EP1210335B1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments
09/14/2005CN1668703A Charge transport compositions on the basis of triarylmethanes and their use in electronic devices
09/14/2005CN1668616A Charge transport compositions comprising fluorizated quinazoline derivatives
09/14/2005CN1668615A Novel benzimidazole derivatives
09/14/2005CN1668612A Novel synthesis of irbesartan
09/14/2005CN1668611A 1-[(indol-3-yl)carbonyl] piperazine derivatives
09/14/2005CN1668610A Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl)-amine derivatives
09/14/2005CN1668601A N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors
09/14/2005CN1668590A 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
09/14/2005CN1668589A Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments
09/14/2005CN1668585A 3, 6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
09/14/2005CN1668584A Pyrrole derivatives as antimycobacterial compounds
09/14/2005CN1668299A Methods for using JNK inhibitors for treating or preventing disease-related wasting
09/14/2005CN1668297A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
09/14/2005CN1666989A Candesartan Cilexetil preparing process
09/14/2005CN1666983A Substituted aminoquinazolinone (thione) derivatives or salts thereof, intermediates thereof, and pest contollers and a method for using the same
09/13/2005US6943188 For manufacture of medicament for use in treating asthma, multiple sclerosis, inflammatory disease
09/13/2005US6943161 For prophylaxis and therapy of inflammation, asthma, arthritis, diabetes, atherosclerosis, ocular diseases, restenosis, autoimmune responses, multiple sclerosis, psoriasis, human cancers, fibrosis of liver, lung and kidney
09/13/2005CA2358724C New cyclobutene-dione derivatives, their method of preparation and pharmaceutical compositions containing them
09/09/2005WO2005083394A2 Methods for detecting anionic and non-anionic proteins using carbocyanine dyes
09/09/2005WO2005082899A1 Oxazolidinone derivatives as antimicrobials
09/09/2005WO2005082895A1 Novel carboxamides for use as xa inhibitors
09/09/2005WO2005082894A1 Cell targeting conjugates
09/09/2005WO2005082892A2 Triazole compounds as antibacterial agents and pharmaceutical compositions containing them
09/09/2005WO2005082866A2 Substituted 1, 2, 4- triazole derivatives as oxytocin antagonists
09/09/2005WO2005082865A1 Fused bicyclic pyrimidine derivative
09/09/2005WO2005082864A1 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
09/09/2005WO2005082862A2 Benzimidazolyl derivatives as kinase inhibitors
09/09/2005WO2005082859A1 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
09/09/2005WO2005082855A1 Novel pyridine derivative and pyrimidine derivative (2)
09/09/2005WO2005082854A1 Novel pyridine derivative and pyrimidine derivative (1)
09/09/2005WO2005082848A2 Method for preparing pyrrolidine oximes
09/09/2005WO2005082079A2 Tetracyclic lactam derivatives and uses thereof
09/09/2005WO2005081687A2 Human hinge core mimetibodies, compositions, methods and uses
09/09/2005WO2005070922A3 Bis-indole pyrroles useful as antimicrobials agents
09/09/2005WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof
09/09/2005WO2005044192A3 Triazole compounds and uses related thereto
09/09/2005WO2005032493A3 Amide compounds as ion channel ligands and uses thereof
09/09/2005WO2005014584A8 3-(indol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones,3-(benzimidazol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones, and 3-(indolin-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones; their preparation and use as modulators of apoptosis
09/09/2005CA2599304A1 Cell targeting conjugates
09/09/2005CA2557398A1 Benzimidazolyl derivatives as kinase inhibitors
09/09/2005CA2556738A1 Tetracyclic lactam derivatives and uses thereof
09/09/2005CA2554767A1 Method for preparing pyrrolidine oximes
09/09/2005CA2543861A1 Novel pyridine derivative and pyrimidine derivative (2)
09/09/2005CA2543859A1 Novel pyridine derivative and pyrimidine derivative (1)
09/08/2005US20050197375 Use of benzimidazole analogs in the treatment of cell proliferation
09/08/2005US20050197364 Amide compounds as ion channel ligands and uses thereof
09/08/2005US20050197353 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases, atherosclerosis, etc.
09/08/2005US20050197350 Melanin Concentrating Hormone (MCH) receptor antagonist; clinical obesity; eating disorders; N-(cis-4-{[4-(dimethylamino)quinolin-2-yl]amino}cyclohexyl)-3-methoxy-benzamide; N-(2-chlorobenzyl)-N'-(cis-4-{[4- -(dimethylamino)-5,6,7,8-tetrahydroquinazolin-2-yl]amino}cyclohexyl)urea; pyrimidine analogs
09/08/2005US20050197338 Substituted pyrazole urea compounds for the treatment of inflammation
09/08/2005US20050197337 Aminomethylpyrimidines as allosteric enhancers of the GABAB receptors
09/08/2005US20050197331 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/08/2005US20050197327 Compounds, compositions, and methods
09/08/2005US20050197325 Substituted spiro azabicyclics as modulators of chemokine receptor activity
09/08/2005US20050197320 Phosphonate and sulfide substituted imidazole compounds; antihuman immunodeficiency viral agents
09/07/2005EP1571148A1 3-phenyl-cinnoline homologue and antitumor agent containing the same
09/07/2005EP1571147A2 Pyrazole analogs acting on cannabinoid receptors
09/07/2005EP1571146A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
09/07/2005EP1571142A1 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/07/2005EP1569919A2 Non-nucleoside reverse transcriptase inhibitors
09/07/2005EP1569918A1 Triazine compounds and their use in forming multidimensional libraries for affinity chromatography
09/07/2005EP1569917A1 Pyrazine-based tubulin inhibitors
09/07/2005EP1569915A2 Spirocyclic ureas, compositions containing such compounds and methods of use
09/07/2005EP1569912A2 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
09/07/2005EP1569910A2 Pesticidal sulphonylaminopyrazoles
09/07/2005EP1569902A1 Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
09/07/2005EP1569654A1 Use of devazepide in combination with an opioid analgesic for potentiating the effect of the analgesic
1 ... 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 ... 626